Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.1 USD | -1.63% | -6.27% | 0.00% |
Business Summary
Number of employees: 31
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel, Oral Small Molecule Therapies for Neuroscience, Inflammation and Immunology Indications
100.0
%
| 0 | nan % | 50 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 50 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,729,172 | 0 | 0 | 65.58 % |
Stock B | 1 | 18,994,104 | 16,869,868 ( 88.82 %) | 0 |
Company contact information
Pipeline Therapeutics, Inc.
10578 Science Center Drive Suite 200
92121, San Diego
+
http://www.contineum-tx.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 395M | |
+52.51% | 56.69B | |
-3.56% | 41B | |
+38.14% | 38.11B | |
-11.22% | 26.89B | |
+13.90% | 25.59B | |
-21.99% | 18.59B | |
-0.17% | 12.39B | |
+26.27% | 11.99B | |
+22.75% | 11.88B |
- Stock Market
- Equities
- CTNM Stock
- Company Contineum Therapeutics, Inc.